IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 22 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,205,000 | $9,797,000 | 3.90% |
| Granite Investment Partners, LLC | 129,627 | $1,054,000 | 0.10% |
| MARATHON CAPITAL MANAGEMENT | 25,000 | $203,000 | 0.09% |
| Granite Point Capital Management, L.P. | 22,673 | $184,000 | 0.05% |
| Financial Architects, Inc | 4,000 | $33,000 | 0.01% |
| REGIONS FINANCIAL CORP | 30,500 | $248,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2,800 | $22,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 14,306 | $116,000 | 0.00% |
| MORGAN STANLEY | 17 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 103 | $1,000 | 0.00% |